Skip to main content
. 2023 Jan 16;2023(1):CD015016. doi: 10.1002/14651858.CD015016.pub2

1. Table 1 ‐ Overview of included studies.

Study ID Country Sample Size GA (weeks) Intervention Comparison
Comparison 1 ‐ Different doses of the same opioid
None
Comparison 2 ‐ Different routes of administration of the same opioid
None
Comparison 3 ‐ Continuous infusion versus bolus administration
Bouwmeester 2001 The Netherlands 68 Not described Continuous morphine Intermittent morphine
Bouwmeester 2003a The Netherlands 63 381 Continuous morphine Intermittent morphine
Bouwmeester 2003b The Netherlands 68 36.1 to 42.1 Continuous morphine Intermittent morphine
Lynn 2000 United States of America 83 Not described Continuous morphine Intermittent morphine
Van Dijk 2002 The Netherlands 181 Not described Continuous morphine Intermittent morphine
Vaughn 1996 United States of America 16 and 202 39.8 to 42.43 Continuous fentanyl Intermittent fentanyl
Comparison 4 ‐ 'As needed' administration versus 'as scheduled' administration
Czarnecki 2020 United States of America 25 36.9 to 39.5 Parent/nurse‐controlled analgesia (morphine) Continuous infusion (morphine)
 

GA stands for "Gestational Age"; ID stands for "Identification".

  1. We extracted the GA for the said 'Group 1' showed in the study, which included newborn infants.
  2. The study had two clearly separate phases: In phase 1, 16 newborn infants were enrolled following randomization; in phase 2, 20 newborn infants were enrolled, without randomization, and therefore their outcome data were not included in this review.
  3. Inserted data reported the range of GA for the study for both groups, in both study's phases.